NASDAQ:SSKN Strata Skin Sciences (SSKN) Stock Price, News & Analysis $1.93 +0.03 (+1.58%) Closing price 04:00 PM EasternExtended Trading$1.97 +0.04 (+2.07%) As of 04:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Strata Skin Sciences Stock (NASDAQ:SSKN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Strata Skin Sciences alerts:Sign Up Key Stats Today's Range$1.87▼$1.9750-Day Range$1.39▼$2.8352-Week Range$1.38▼$3.86Volume90,691 shsAverage Volume978,228 shsMarket Capitalization$8.05 millionP/E RatioN/ADividend YieldN/APrice Target$6.00Consensus RatingHold Company Overview Strata Skin Sciences, Inc. is a medical technology company headquartered in Edison, New Jersey, that specializes in developing and commercializing dermatological devices and therapies. The company’s flagship offering is the XTRAC® excimer laser system, an FDA‐cleared, 308-nanometer ultraviolet light device used to treat skin conditions such as vitiligo and psoriasis. Strata’s product suite also includes associated accessories and disposables, as well as clinical services and training programs designed to support dermatology practices and improve patient outcomes. Strata Skin Sciences expanded its portfolio and market presence through the strategic acquisition of PhotoMedex in 2019, bringing together complementary phototherapy and energy-based technologies under one roof. This integration enabled the company to widen its geographic footprint, serving physicians and clinics across the United States and through select international distribution partners in Europe and Asia. Strata continues to invest in clinical research, product enhancements and next-generation platforms aimed at addressing a range of dermatologic disorders with noninvasive treatment modalities. Under the leadership of Chairman and Chief Executive Officer David J. Peskin, Strata Skin Sciences maintains a direct sales force of clinical specialists who provide installation, training and ongoing support for its laser and light‐based systems. The company’s operational strategy focuses on fostering long-term partnerships with dermatology practices, promoting the adoption of its technologies through peer-reviewed publications, educational initiatives and real-world evidence studies. As a result, Strata has positioned itself as a focused provider of advanced phototherapy solutions within the skin disease market.AI Generated. May Contain Errors. Read More Strata Skin Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreSSKN MarketRank™: Strata Skin Sciences scored higher than 50% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingStrata Skin Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialStrata Skin Sciences has a consensus price target of $6.00, representing about 210.1% upside from its current price of $1.94.Amount of Analyst CoverageStrata Skin Sciences has only been the subject of 1 research reports in the past 90 days.Read more about Strata Skin Sciences' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Strata Skin Sciences are expected to grow in the coming year, from ($1.05) to ($1.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Strata Skin Sciences is -0.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Strata Skin Sciences is -0.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioStrata Skin Sciences has a P/B Ratio of 1.63. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Strata Skin Sciences' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.82% of the float of Strata Skin Sciences has been sold short.Short Interest Ratio / Days to CoverStrata Skin Sciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Strata Skin Sciences has recently increased by 15.98%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldStrata Skin Sciences does not currently pay a dividend.Dividend GrowthStrata Skin Sciences does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.82% of the float of Strata Skin Sciences has been sold short.Short Interest Ratio / Days to CoverStrata Skin Sciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Strata Skin Sciences has recently increased by 15.98%, indicating that investor sentiment is decreasing significantly. News and Social Media3.1 / 5News Sentiment0.64 News SentimentStrata Skin Sciences has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Strata Skin Sciences this week, compared to 1 article on an average week.Search Interest70 people have searched for SSKN on MarketBeat in the last 30 days. This is an increase of 1,650% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Strata Skin Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders39.00% of the stock of Strata Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 32.43% of the stock of Strata Skin Sciences is held by institutions.Read more about Strata Skin Sciences' insider trading history. Receive SSKN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Strata Skin Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SSKN Stock News HeadlinesSTRATA Study Shows Excimer Laser Plus Tacrolimus Boosts Psoriasis OutcomesOctober 6 at 2:04 AM | msn.comMarking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences’ XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic DermatitisOctober 3, 2025 | markets.businessinsider.comTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…October 7 at 2:00 AM | Brownstone Research (Ad)Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences' XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic DermatitisOctober 3, 2025 | globenewswire.comSTRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical ...September 30, 2025 | markets.businessinsider.comSTRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in PsoriasisSeptember 30, 2025 | globenewswire.comSTRATA Skin Sciences Study Shows Breakthrough in Vitiligo Combination TherapySeptember 28, 2025 | msn.comSTRATA Skin Sciences stock soars after promising vitiligo study resultsSeptember 23, 2025 | au.investing.comSee More Headlines SSKN Stock Analysis - Frequently Asked Questions How have SSKN shares performed this year? Strata Skin Sciences' stock was trading at $2.91 at the beginning of 2025. Since then, SSKN shares have decreased by 33.5% and is now trading at $1.9350. How were Strata Skin Sciences' earnings last quarter? Strata Skin Sciences, Inc. (NASDAQ:SSKN) announced its quarterly earnings data on Wednesday, August, 13th. The medical device company reported ($0.60) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.27) by $0.33. The medical device company had revenue of $7.70 million for the quarter, compared to the consensus estimate of $8.56 million. Strata Skin Sciences had a negative net margin of 35.13% and a negative trailing twelve-month return on equity of 266.94%. Read the conference call transcript. When did Strata Skin Sciences' stock split? Shares of Strata Skin Sciences reverse split on the morning of Friday, June 7th 2024.The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Strata Skin Sciences? Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Strata Skin Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Strata Skin Sciences investors own include Amarin (AMRN), AbbVie (ABBV), OPKO Health (OPK), AT&T (T), Agile Therapeutics (AGRX), Advanced Micro Devices (AMD) and Avino Silver & Gold Mines (ASM). Company Calendar Last Earnings8/13/2025Today10/07/2025Next Earnings (Estimated)11/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryMedical Equipment Current SymbolNASDAQ:SSKN CIK1051514 Webwww.strataskinsciences.com Phone(215) 619-3200Fax215-619-3208Employees120Year Founded1989Price Target and Rating Average Price Target for Strata Skin Sciences$6.00 High Price Target$6.00 Low Price Target$6.00 Potential Upside/Downside+206.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($2.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.09 million Net Margins-35.13% Pretax Margin-35.65% Return on Equity-266.94% Return on Assets-32.66% Debt Debt-to-Equity Ratio49.58 Current Ratio0.98 Quick Ratio0.75 Sales & Book Value Annual Sales$33.56 million Price / Sales0.24 Cash FlowN/A Price / Cash FlowN/A Book Value$1.19 per share Price / Book1.65Miscellaneous Outstanding Shares4,170,000Free Float2,544,000Market Cap$8.18 million OptionableNot Optionable Beta0.50 Social Links 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:SSKN) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Strata Skin Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Strata Skin Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.